1. A novel adoptive synthetic TCR and antigen receptor (STAR) T‐Cell therapy for B‐Cell acute lymphoblastic leukemia. Issue 8 (12th May 2022) Authors: Wang, Jiasheng; Zhang, Xian; Zhou, Zhixiao; Liu, Yue; Yu, Li; Jia, Lemei; Yang, Junfang; Li, Jingjing; Yu, Hanyang; Li, Wenzhong; Liu, Guangna; Rui, Wei; Zheng, Hongli; Zhao, Xueqiang; Lin, Xin; Lu, Peihua Journal: American journal of hematology Issue: Volume 97:Issue 8(2022) Page Start: 992 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anti‐CD19 CAR T as a feasible therapy for refractory/relapsed mixed phenotype acute leukemia patients. Issue 10 (4th April 2022) Authors: Li, Xiangqun; Chen, Kylan; Zhang, Hailong; Zhang, Xian; Yang, Junfang; Liu, Jing; Zheng, Jianwei; Dong, Fei; Zhu, Yongbo; Yu, Jiao; Zhang, Haihong; Lu, Peihua; Chen, Bo Journal: Pediatric blood & cancer Issue: Volume 69:Issue 10(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CAR T-cell therapies in China: rapid evolution and a bright future. Issue 12 (December 2022) Authors: Hu, Yongxian; Feng, Jingjing; Gu, Tianning; Wang, Linqin; Wang, Yiyun; Zhou, Linghui; Hong, Ruimin; Tan Su Yin, Elaine; Zhang, Mingming; Lu, Peihua; Huang, He Journal: Lancet Issue: Volume 9:Issue 12(2022) Page Start: e930 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Complementary Nck1/2 Signaling in Podocytes Controls α Actinin-4–Mediated Actin Organization, Adhesion, and Basement Membrane Composition. Issue 8 (August 2022) Authors: Martin, Claire E.; Phippen, Noah J.; Keyvani Chahi, Ava; Tilak, Manali; Banerjee, Sara L.; Lu, Peihua; New, Laura A.; Williamson, Casey R.; Platt, Mathew J.; Simpson, Jeremy A.; Krendel, Mira; Bisson, Nicolas; Gingras, Anne-Claude; Jones, Nina Journal: Journal of the American Society of Nephrology Issue: Volume 33:Issue 8(2022) Page Start: 1546 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Complete remission of refractory juvenile acute myeloid leukaemia with RUNX1‐PRDM16 in Bloom syndrome after haematopoietic stem cell transplantation. (26th May 2020) Authors: Nie, Daijing; Zhang, Jing; Xiong, Min; Wang, Fang; Cao, Panxiang; Zhang, Yang; Chen, Xue; Chen, Jiaqi; Ma, Xiaoli; Zhou, Xiaosu; Wu, Qisheng; Li, Xvxin; Liu, Lili; Liu, Ming; Tian, Wenjun; Wu, Ping; Wang, Tong; Wang, Hui; Lu, Peihua; Liu, Hongxing Journal: British journal of haematology Issue: Volume 190:Number 3(2020) Page Start: e166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia. Issue 16 (22nd June 2018) Authors: Zhang, Yang; Wang, Fang; Chen, Xue; Zhang, Yu; Wang, Mingyu; Liu, Hong; Cao, Panxiang; Ma, Xiaoli; Wang, Tong; Zhang, Jianping; Zhang, Xian; Lu, Peihua; Liu, Hongxing Journal: Cancer Issue: Volume 124:Issue 16(2018) Page Start: 3329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cytoplasmic CD79a is a promising biomarker for B lymphoblastic leukemia follow up post CD19 CAR-T therapy. Issue 2 (28th January 2022) Authors: Chen, Man; Fu, Minjing; Wang, Aixian; Wu, Xueying; Zhen, Junyi; Gong, Meiwei; Zhang, Xian; Yue, Guanlan; Du, Qing; Zhao, Wei; Zhao, Yanli; Lu, Peihua; Wang, Hui Journal: Leukemia & lymphoma Issue: Volume 63:Issue 2(2022) Page Start: 426 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. DNTT activation, TdT‐aided gene length mutation, and better prognosis in ATG‐based regimen allo‐HSCT in AML. Issue 5 (8th February 2023) Authors: Zhou, Xiaosu; Nie, Daijing; Zhang, Yang; Liu, Zhixiu; Zhao, Yanli; Zhang, Jianping; Wang, Fang; Fang, Jiancheng; Cao, Panxiang; Chen, Xue; Ma, Xiaoli; Yuan, Lili; Chen, Jiaqi; Tan, Yincheng; Chen, Qihui; Liu, Ming; Liu, Mingyue; Liu, Yijun; Wu, Qisheng; Lu, Peihua Journal: Molecular carcinogenesis Issue: Volume 62:Issue 5(2023) Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy of pp65‐specific TCR‐T cell therapy in treating cytomegalovirus infection after hematopoietic stem cell transplantation. Issue 11 (22nd September 2022) Authors: Liu, Guangna; Chen, Hua; Cao, Xingyu; Jia, Lemei; Rui, Wei; Zheng, Hongli; Huang, Daosheng; Liu, Fang; Liu, Yue; Zhao, Xueqiang; Lu, Peihua; Lin, Xin Journal: American journal of hematology Issue: Volume 97:Issue 11(2022) Page Start: 1453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase 1 study of C-CAR088, a novel humanized anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma. Issue 9 (13th September 2022) Authors: Qu, Xiaoyan; An, Gang; Sui, Weiwei; Wang, Tingyu; Zhang, Xian; Yang, Junfang; Zhang, Yan; Zhang, Lu; Zhu, Dan; Huang, Jiaqi; Zhu, Shigui; Yao, Xin; Li, Jing; Zheng, Chengxiao; Zhu, Kevin; Wei, Yutian; Lv, Xiaoteng; Lan, Liping; Yao, Yihong; Zhou, Daobin Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 9(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗